Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia

Published:2022-11-26 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tada Hayato¹,Okada Hirofumi¹,Nohara Atsushi²,Toh Ryuji³,Harada Amane⁴,Murakami Katsuhiro⁴,Iino Takuya⁴,Nagao Manabu³,Ishida Tatsuro⁵,Hirata Ken-ichi³,Takamura Masayuki¹,Kawashiri Masa-aki⁶

Affiliation:

1. Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences

2. Department of Genetics, Ishikawa Prefectural Central Hospital

3. Division of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine

4. Central Research Laboratories, Sysmex Corporation

5. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

6. Department of Internal Medicine, Kaga Medical Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-22-0560/_pdf

Reference33 articles.

1. 1. Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: Meta-analyses of 11 million subjects. J Am Coll Cardiol 2020; 75: 2553–2566.

2. 2. Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis. Circulation 2020; 141: 1742–1759.

3. 3. Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J 2017; 38: 1573–1579.

4. 4. Nohara A, Tada H, Ogura M, Okazaki S, Ono K, Shimano H, et al. Homozygous familial hypercholesterolemia. J Atheroscler Thromb 2021; 28: 665–678.

5. 5. Mata P, Alonso R, Pérez de Isla L. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: Does one size fit all? Curr Opin Lipidol 2018; 29: 445–452.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17

2. A fascinating association between HDL as a multi-potent particle and hypertension;Hypertension Research;2024-03-14

3. <i>Circulation Journal</i> Awards for the Year 2023;Circulation Journal;2024-02-22

4. Rethinking ‘good cholesterol’ for cardiovascular risk stratification;QJM: An International Journal of Medicine;2023-11-06

5. Is High-Density Lipoprotein Functionality Useful as a Residual Risk Marker for Familial Hypercholesterolemia?;Circulation Journal;2023-05-25